Armstrong Shaw Associates Inc Abb Vie Inc. Transaction History

Armstrong Shaw Associates Inc

$94.5 Million
Q3 2023

A detailed history of Armstrong Shaw Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Armstrong Shaw Associates Inc holds 24,253 shares of ABBV stock, worth $4.26 Million. This represents 3.82% of its overall portfolio holdings.

Number of Shares

24,253

Previous 24,253 -0.0%

Holding current value

$4.26 Million

Previous $3.27 Million 10.65%

% of portfolio

3.82%

Previous 3.35%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $479,288 - $596,443	-3,617 Reduced 12.98%	24,253 $3.27 Million
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $104,697 - $120,574	-724 Reduced 2.53%	27,870 $4.44 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $45,503 - $54,571	-329 Reduced 1.14%	28,594 $4.62 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $33,667 - $37,507	-320 Reduced 1.09%	28,923 $3.26 Million
Q1 2021 May 05, 2021	SELL	$102.3 - $112.62 $28,848 - $31,758	-282 Reduced 0.96%	29,243 $3.17 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $30,344 - $40,968	-377 Reduced 1.26%	29,525 $3.16 Million
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $448,804 - $600,567	-6,117 Reduced 16.98%	29,902 $2.94 Million
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $27,412 - $41,560	-425 Reduced 1.17%	36,019 $2.74 Million
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $223,603 - $279,775	-3,100 Reduced 7.84%	36,444 $3.23 Million
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $92,571 - $118,327	-1,409 Reduced 3.44%	39,544 $2.88 Million
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $47,055 - $55,381	-610 Reduced 1.47%	40,953 $3.3 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $68,118 - $84,008	-875 Reduced 2.06%	41,563 $3.83 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $66,949 - $74,426	-753 Reduced 1.74%	42,438 $4.01 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $6,194 - $7,329	69 Added 0.16%	43,191 $4 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $78,024 - $104,482	-848 Reduced 1.93%	43,122 $4.08 Million
Q4 2017 Jan 25, 2018	BUY	$89.56 - $98.21 $20,867 - $22,882	233 Added 0.53%	43,970 $4.25 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $3.06 Million - $3.9 Million	43,737	43,737 $3.89 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Shaw Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Shaw Associates Inc with notifications on news.

Account

Armstrong Shaw Associates Inc Abb Vie Inc. Transaction History